The synthesis of a nanodrug using metal-based nanozymes conjugated with ginsenoside Rg3 for pancreatic cancer therapy-Reference-Cited by-同舟云学术

The synthesis of a nanodrug using metal-based nanozymes conjugated with ginsenoside Rg3 for pancreatic cancer therapy

Published:2022 Issue:1 Volume:4 Page:190-199
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Zhao Xiaoxiong¹²,Wu Jicheng³⁴,Zhang Kaixin³⁴,Guo Danjing⁵,Hong Liangjie⁵,Chen Xinhua²⁵,Wang Ben³⁴,Song Yujun¹²^ORCID

Affiliation:

1. Center for Modern Physics Technology, School of Mathematics and Physics, University of Science and Technology Beijing, Beijing 100083, China

2. Zhejiang Key Laboratory for Pulsed Power Technology Translational Medicine, Hangzhou 310000, China

3. Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China

4. Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China

5. Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China

Abstract

The coupling of nanozymes with ginsenoside Rg3 to form a nanodrug completely compensates for their respective defects and results in obvious anticancer synergistic effects, which provides a clear direction for the subsequent clinical application.

Funder

National Natural Science Foundation of China

National Science and Technology Planning Project

National Key Research and Development Program of China

Natural Science Foundation of Zhejiang Province

Zhejiang University

Chinese Academy of Engineering

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link